{"nct_id":"NCT02332668","title":"A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)","status":"RECRUITING","status_verified_date":"2025-07","start_date":"2015-03-18","start_date_type":"ACTUAL","primary_completion_date":"2027-10-25","primary_completion_date_type":"ESTIMATED","completion_date":"2027-10-25","completion_date_type":"ESTIMATED","phases":["PHASE1","PHASE2"],"tickers":["MRK"]}